Insulet Corp PODD:NASDAQ

RT Quote | NASDAQ | USD
Last | 03/04/21 EST
242.36quote price arrow down-10.74 (-4.24%)
Volume
601,257
52 week range
121.00 - 298.43

...

Loading . . .

KEY STATS

  • Open250.32
  • Day High254.10
  • Day Low240.06
  • Prev Close242.36
  • 52 Week High298.43
  • 52 Week High Date01/20/21
  • 52 Week Low121.00
  • 52 Week Low Date03/18/20
  • Market Cap16.015B
  • Shares Out66.08M
  • 10 Day Average Volume0.51M
  • Dividend-
  • Dividend Yield-
  • Beta0.65
  • 1 Year % Change35.36

RATIOS/PROFITABILITY

  • EPS (TTM)0.10
  • P/E (TTM)2,411.54
  • Fwd P/E (NTM)439.85
  • EBITDA (MRQ)106.90M
  • ROE (MRQ)2.00%
  • Revenue (MRQ)904.40M
  • Gross Margin (MRQ)64.39%
  • Net Margin (MRQ)0.75%
  • Debt To Equity (MRQ)175.50%

EVENTS

  • Earnings Date05/05/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Insulet Corp News

There is no recent news for this security.

Latest PODD News From Our Partners

QUOTE FINDER

Profile

MORE
Insulet Corporation is engaged in the development, manufacturing and sale of the OmniPod Insulin Management System (the OmniPod System), an insulin delivery system for people with insulin-dependent diabetes. The Omnipod System features a self-adhesive disposable tubeless Omnipod device, which is worn on the body for approximately three days at a time and its wireless companion, the handheld Personal Diabetes Manager (PDM). The Omnipod System features two discreet devices that...
Timothy Scannell
Chairman
Shacey Petrovic
President
Charles Alpuche
Chief Operating Officer
Wayde McMillan
Chief Financial Officer
Bret Christensen
Executive Vice President
Address
100 Nagog Park
Acton, MA
01720-3440
United States